These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17622926)

  • 41. Which patients undergoing cardiopulmonary bypass should be assessed for development of heparin-induced thrombocytopenia?
    Cummins D; Halil O; Amin S
    Thromb Haemost; 1995 May; 73(5):890. PubMed ID: 7482421
    [No Abstract]   [Full Text] [Related]  

  • 42. High ANTI-PF4/Heparin Antibodies Titer and Thromboses Due to Infection 9 Months After Cessation of Heparin in Hemodialyzed Patient With Heparin-Induced Thrombocytopenia.
    Sain M; Burilovic V; Tomicic M; Jelicic I
    Ther Apher Dial; 2018 Oct; 22(5):558-559. PubMed ID: 29856115
    [No Abstract]   [Full Text] [Related]  

  • 43. Heparin-induced thrombocytopenia with thrombosis syndrome managed with plasmapheresis.
    Kramer R; Oberg-Higgins P; Russo L; Braxton JH
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):439-41. PubMed ID: 19129243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Selleng S; Greinacher A; Ittermann T; Wollert HG
    Am Heart J; 2009 Jul; 158(1):e15. PubMed ID: 19540379
    [No Abstract]   [Full Text] [Related]  

  • 45. Beyond the platelet count: heparin antibodies as independent risk predictors.
    Stribling WK; Slaughter TF; Houle TT; Sane DC
    Am Heart J; 2007 Jun; 153(6):900-6. PubMed ID: 17540189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of heparin-induced thrombocytopenia from heparin-bonded vascular prostheses.
    Mureebe L; Graham JA; Bush RL; Silver D
    Ann Vasc Surg; 2007 Nov; 21(6):719-22. PubMed ID: 17980795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. eComment: Heparin-induced thrombocytopenia.
    Bockeria L; Samsonova N; Klimovich L
    Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):1025. PubMed ID: 19919964
    [No Abstract]   [Full Text] [Related]  

  • 48. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery.
    Kerendi F; Thourani VH; Puskas JD; Kilgo PD; Osgood M; Guyton RA; Lattouf OM
    Ann Thorac Surg; 2007 Nov; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.
    Amiral J; Bridey F; Dreyfus M; Vissoc AM; Fressinaud E; Wolf M; Meyer D
    Thromb Haemost; 1992 Jul; 68(1):95-6. PubMed ID: 1514184
    [No Abstract]   [Full Text] [Related]  

  • 51. Experts' opinion or the serotonin release assay as a gold standard for the diagnosis of heparin-induced thrombocytopenia (HIT)?
    Tardy B; Presles E; Akrour M; de Maistre E; Lecompte T; Tardy-Poncet B
    J Thromb Haemost; 2011 Aug; 9(8):1667-9. PubMed ID: 21645232
    [No Abstract]   [Full Text] [Related]  

  • 52. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
    Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA
    Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin-induced thrombocytopenia (HIT).
    Evans NS; Gomes M
    Vasc Med; 2017 Aug; 22(4):353-355. PubMed ID: 28606001
    [No Abstract]   [Full Text] [Related]  

  • 54. Heparin-induced thrombocytopenia.
    Baroletti SA; Goldhaber SZ
    Circulation; 2006 Aug; 114(8):e355-6. PubMed ID: 16923760
    [No Abstract]   [Full Text] [Related]  

  • 55. Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.
    Wanaka K; Matsuo T; Matsuo M; Kaneko C; Miyashita K; Asada R; Matsushima H; Nakajima Y
    J Thromb Haemost; 2010 Mar; 8(3):616-8. PubMed ID: 20050999
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery.
    Bauer TL; Arepally G; Konkle BA; Mestichelli B; Shapiro SS; Cines DB; Poncz M; McNulty S; Amiral J; Hauck WW; Edie RN; Mannion JD
    Circulation; 1997 Mar; 95(5):1242-6. PubMed ID: 9054855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients.
    Mureebe L; Coats RD; Silliman WR; Shuster TA; Nichols WK; Silver D
    Surgery; 2004 Oct; 136(4):848-53. PubMed ID: 15467671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.
    Arepally GM; Padmanabhan A
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):141-152. PubMed ID: 33267665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.